Company / Revenue per Share
Vanda Pharmaceuticals Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.30
FY2025
5-year range
$3.30 / $4.73
FY2021-FY2025
Trend
-25.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $1.17 in FY2016 to $4.73 in FY2023.
Based on SEC 10-K filings.
3.30 in FY2025 with a 5-year CAGR of -1.7%.
Declined from $4.73 to $3.30 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -9.4%
- 5-Year CAGR
- -1.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 25.3% year-over-year.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.30 | -25.3% |
| FY2024 | $4.42 | -6.6% |
| FY2023 | $4.73 | +6.6% |
| FY2022 | $4.44 | +7.2% |
| FY2021 | $4.14 | +14.8% |
| FY2020 | $3.61 | +14.6% |
| FY2019 | $3.15 | -3.2% |
| FY2018 | $3.25 | +30.1% |
| FY2017 | $2.50 | +113.3% |
| FY2016 | $1.17 | +43.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026